Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives.
Biomolecules
; 12(3)2022 03 02.
Article
en En
| MEDLINE
| ID: mdl-35327582
Cardiovascular diseases (CVDs) are still a major cause of global mortality and disability, seriously affecting people's lives. Due to the severity and complexity of these diseases, it is important to find new regulatory mechanisms to treat CVDs. Ferroptosis is a new kind of regulatory cell death currently being investigated. Increasing evidence showed that ferroptosis plays an important role in CVDs, such as in ischemia/reperfusion injury, heart failure, cardiomyopathy, and atherosclerosis. Protecting against CVDs by targeting ferroptosis is a promising approach; therefore, in this review, we summarized the latest regulatory mechanism of ferroptosis and the current studies related to each CVD, followed by critical perspectives on the ferroptotic treatment of CVDs and the future direction of this intriguing biology.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Enfermedades Cardiovasculares
/
Daño por Reperfusión
/
Ferroptosis
/
Cardiomiopatías
Límite:
Humans
Idioma:
En
Año:
2022
Tipo del documento:
Article